|
Trastuzumab SC Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Herceptin Hylecta
San Francisco, California1 trial
ATEMPT 2.0: Adjuvant T-DM1 vs TH
UCSF Helen Diller Family Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.